3M said net sales for Q1 2024 fell 0.3% year on year to $8,003 million, and GAAP diluted earnings per share were $1.67, compared with $1.76 a year earlier. Adjusted EPS rose 21% to $2.39.

1. 01

   3M said net sales for Q1 2024 fell 0.3% year on year to $8,003 million, and GAAP diluted earnings per share were $1.67, compared with $1.76 a year earlier. Adjusted EPS rose 21% to $2.39.

2. 02

   The company said it completed the spin-off of its health care business on April 1, 2024, which formally launched Solventum Corporation as an independent company. 3M said it retains 19.9% of Solventum's common stock outstanding and plans to monetize it within 5 years of the spin-off.

3. 03

   The company said the public water supplier settlement received final court approval and that its pre-tax present value commitment is up to $10.3 billion, payable over 13 years. For the Combat Arms Earplugs settlement, it said more than 99% of claimants are participating, with a total payment of up to $6.0 billion, or a total pre-tax present value of $5.3 billion.

4. 04

   The company set its full-year 2024 outlook, reflecting Solventum as a discontinued operation including Q1. It guided to adjusted EPS of $6.80 to $7.30 and adjusted organic sales growth of flat to +2%. It said its dividend payout ratio after the spin-off is expected to be about 40% of adjusted free cash flow.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.